Clinical pharmacologic concepts for the rational selection and use of drugs for the management of dyslipidemia.


The long-term clinical benefits of lowering serum lipid levels have been demonstrated in multiple clinical trials in recent years. These include coronary artery disease regression and decreases in the incidence of adverse clinical events, such as myocardial infarction or refractory ischemia. Reductions in overall mortality have also been demonstrated. The… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics